i2E & Plains Ventures Surpasses $100M Milestone in Total Investments
Innovation 2 Enterprise
NOVEMBER 21, 2024
Notable investment successes include: Crescendo Bioscience , an early i2E investment, was acquired for $270 million in 2014. To date, $42 million has been invested in life sciences and advanced healthcare solutions, with 109 companies in Tulsa, 121 companies in Oklahoma City, and many others throughout the state receiving capital so far.
Let's personalize your content